These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1675050)

  • 1. Topical flurbiprofen pretreatment does not block apraclonidine's effect on aqueous flow in humans.
    McCannel C; Koskela T; Brubaker RF
    Arch Ophthalmol; 1991 Jun; 109(6):810-1. PubMed ID: 1675050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
    Maus TL; Nau C; Brubaker RF
    Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of topical flurbiprofen on the intraocular pressure lowering effects of apraclonidine and timolol.
    Sulewski ME; Robin AL; Cummings HL; Arkin LM
    Arch Ophthalmol; 1991 Jun; 109(6):807-9. PubMed ID: 1675049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apraclonidine and timolol. Combined effects in previously untreated normal subjects.
    Koskela T; Brubaker RF
    Arch Ophthalmol; 1991 Jun; 109(6):804-6. PubMed ID: 1675048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans.
    Schadlu R; Maus TL; Nau CB; Brubaker RF
    Arch Ophthalmol; 1998 Nov; 116(11):1441-4. PubMed ID: 9823343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145).
    Gharagozloo NZ; Relf SJ; Brubaker RF
    Ophthalmology; 1988 Sep; 95(9):1217-20. PubMed ID: 3062536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular effects of apraclonidine in Horner syndrome.
    Morales J; Brown SM; Abdul-Rahim AS; Crosson CE
    Arch Ophthalmol; 2000 Jul; 118(7):951-4. PubMed ID: 10900109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha(2)-adrenergic agonists on lipopolysaccharide-induced aqueous flare elevation in pigmented rabbits.
    Watanabe K; Hayasaka S; Hiraki S; Matsumoto M; Kadoi C; Nagaki Y
    Jpn J Ophthalmol; 2001; 45(3):221-6. PubMed ID: 11369369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apraclonidine protection of the blood-aqueous barrier from traumatic break-down.
    Bonomi L; Bellucci R; Pagliarusco A; Stefani L
    J Ocul Pharmacol Ther; 1995; 11(1):25-35. PubMed ID: 8535954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of apraclonidine on blood-aqueous barrier permeability to plasma protein in man.
    Mori M; Araie M
    Exp Eye Res; 1992 Apr; 54(4):555-9. PubMed ID: 1352504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans.
    Maus TL; Larsson LI; McLaren JW; Brubaker RF
    Arch Ophthalmol; 1997 Jan; 115(1):45-9. PubMed ID: 9006424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.
    Larsson LI
    Arch Ophthalmol; 2001 Apr; 119(4):492-5. PubMed ID: 11296014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of topically applied flurbiprofen, diclofenac, tolmetin, and suprofen for the treatment of experimentally induced blood-aqueous barrier disruption in dogs.
    Ward DA
    Am J Vet Res; 1996 Jun; 57(6):875-8. PubMed ID: 8725816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.
    Gabelt BT; Robinson JC; Hubbard WC; Peterson CM; Debink N; Wadhwa A; Kaufman PL
    Exp Eye Res; 1994 Dec; 59(6):633-44. PubMed ID: 7698258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
    Robin AL; Ritch R; Shin D; Smythe B; Mundorf T; Lehmann RP
    Trans Am Ophthalmol Soc; 1995; 93():421-38; discussion 439-41. PubMed ID: 8719690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group.
    Robin AL; Ritch R; Shin DH; Smythe B; Mundorf T; Lehmann RP
    Am J Ophthalmol; 1995 Oct; 120(4):423-32. PubMed ID: 7573299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep.
    Vanlandingham BD; Maus TL; Brubaker RF
    Ophthalmology; 1998 Aug; 105(8):1537-40. PubMed ID: 9709770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous flow in humans after adrenalectomy.
    Maus TL; Young WF; Brubaker RF
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3325-31. PubMed ID: 8045722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of brimonidine on aqueous humor dynamics in human eyes.
    Toris CB; Gleason ML; Camras CB; Yablonski ME
    Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ibopamine on aqueous humor production in normotensive humans.
    McLaren JW; Herman DC; Brubaker RF; Nau CB; Wayman LL; Ciarniello MG; Rosignoli MT; Dionisio P
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4853-8. PubMed ID: 14578408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.